Long Non‑coding RNAs, Lipid Metabolism and Cancer (Review)

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2023 Sep 4

PMID 37664674

Authors

Zhen-Dong Zhang

Xin-Rui Hou

Xiao-Lan Cao

Xiao-Ping Wang

Affiliations

Soon will be listed here.

Abstract

Cancer has emerged as the most common cause of death in China. The change in lipid metabolism has been confirmed to have a role in several tumor types, such as esophageal, gastric, colorectal and liver cancer. Cancer cells use lipid metabolism for energy and then rapidly proliferate, invade and migrate. The main pathway by which cancer cell lipid metabolism influences cancer progression is increased fatty acid synthesis. Long non-coding (lnc)RNAs are important ncRNAs that were indicated to have significant roles in the development of human tumors. They are considered potential tumor biomarkers. Increased lipid synthesis or uptake due to deregulation of lncRNAs contributes to rapid tumor growth. In the present review, current studies on the relationship between lncRNAs, lipid metabolism and the occurrence and development of tumors were collated and summarized, and their mechanism of action was discussed. The review is expected to provide a theoretical basis for tumor treatment and prognosis evaluation based on the effective regulation of lncRNAs and lipid metabolism.

Citing Articles

Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors.

Liao B, Wang J, Yuan Y, Luo H, Ouyang X Cancer Cell Int. 2024; 24(1):122.

PMID: 38555465 PMC: 10981830. DOI: 10.1186/s12935-024-03285-6.

References

Shi L, Duan R, Sun Z, Jia Q, Wu W, Wang F . LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer. Cell Death Differ. 2023; 30(6):1517-1532. PMC: 10244348. DOI: 10.1038/s41418-023-01157-6. View

Liu X, Liang Y, Song R, Yang G, Han J, Lan Y . Long non-coding RNA NEAT1-modulated abnormal lipolysis via ATGL drives hepatocellular carcinoma proliferation. Mol Cancer. 2018; 17(1):90. PMC: 5953401. DOI: 10.1186/s12943-018-0838-5. View

Wen Y, Xiong X, Zaytseva Y, Napier D, Vallee E, Li A . Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018; 9(3):265. PMC: 5833501. DOI: 10.1038/s41419-018-0330-6. View

Chen J, Alduais Y, Zhang K, Zhu X, Chen B . CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma. J Cell Mol Med. 2021; 25(19):9199-9213. PMC: 8500980. DOI: 10.1111/jcmm.16815. View

Lin W, Zhou Q, Wang C, Zhu L, Bi C, Zhang S . LncRNAs regulate metabolism in cancer. Int J Biol Sci. 2020; 16(7):1194-1206. PMC: 7053319. DOI: 10.7150/ijbs.40769. View

Ghafouri-Fard S, Shoorei H, Dashti S, Branicki W, Taheri M . Expression profile of lncRNAs and miRNAs in esophageal cancer: Implications in diagnosis, prognosis, and therapeutic response. J Cell Physiol. 2020; 235(12):9269-9290. DOI: 10.1002/jcp.29825. View

DU Y, Kong G, You X, Zhang S, Zhang T, Gao Y . Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem. 2012; 287(31):26302-11. PMC: 3406714. DOI: 10.1074/jbc.M112.342113. View

Lin Y, Xiao Y, Liu S, Hong L, Shao L, Wu J . Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer. BMC Med Genomics. 2022; 15(1):221. PMC: 9590147. DOI: 10.1186/s12920-022-01369-8. View

Christensen L, True K, Hamilton M, Nielsen M, Damas N, Damgaard C . SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism. Mol Oncol. 2016; 10(8):1266-82. PMC: 5423192. DOI: 10.1016/j.molonc.2016.06.003. View

10.

Tiong T, Weng P, Wang C, Setiawan S, Yadav V, Pikatan N . Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells. Int J Mol Sci. 2022; 23(13). PMC: 9266857. DOI: 10.3390/ijms23137283. View

11.

Butler L, Perone Y, Dehairs J, Lupien L, de Laat V, Talebi A . Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. Adv Drug Deliv Rev. 2020; 159:245-293. PMC: 7736102. DOI: 10.1016/j.addr.2020.07.013. View

12.

Liu C, Li H, Chu F, Zhou X, Xie R, Wei Q . Long non‑coding RNAs: Key regulators involved in metabolic reprogramming in cancer (Review). Oncol Rep. 2021; 45(5). DOI: 10.3892/or.2021.8005. View

13.

Yang Y, Jin L, He J, Wang R, Wang Y, Bai J . Upregulation LncRNA MEG3 expression suppresses proliferation and metastasis in melanoma via miR-208/SOX4. Mol Cell Biochem. 2022; 478(2):407-414. DOI: 10.1007/s11010-022-04515-z. View

14.

Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A . Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis. 2019; 18(1):29. PMC: 6347819. DOI: 10.1186/s12944-019-0977-8. View

15.

Cheng C, Geng F, Cheng X, Guo D . Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018; 38(1):27. PMC: 5993136. DOI: 10.1186/s40880-018-0301-4. View

16.

Toker J, Iorgulescu J, Ling A, Villa G, Gadet J, Parida L . Clinical Importance of the lncRNA NEAT1 in Cancer Patients Treated with Immune Checkpoint Inhibitors. Clin Cancer Res. 2023; 29(12):2226-2238. PMC: 10330151. DOI: 10.1158/1078-0432.CCR-22-3714. View

17.

Hu B, Lin J, Yang X, Sang X . Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review. Cell Prolif. 2020; 53(3):e12772. PMC: 7106960. DOI: 10.1111/cpr.12772. View

18.

Chen M, Zhang C, Liu W, Du X, Liu X, Xing B . Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming. Mol Ther. 2022; 30(6):2354-2369. PMC: 9171153. DOI: 10.1016/j.ymthe.2022.02.020. View

19.

Xu K, Xia P, Gongye X, Zhang X, Ma S, Chen Z . A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression. Mol Metab. 2022; 63:101540. PMC: 9287641. DOI: 10.1016/j.molmet.2022.101540. View

20.

McCabe E, Rasmussen T . lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 2020; 75:38-48. DOI: 10.1016/j.semcancer.2020.12.012. View